Insulin Delivery Devices Market Size, Share, Analysis, Industry Report and Forecast 2019-2025
The global insulin delivery devices market to showcase a lucrative growth rate during the forecast period. The growth in the market is anticipated due to increased technological advancement in insulin therapy by extensive R&D by major market players of the insulin delivery devices market. At present, scientists and researchers have not been able to found another alternative for curing diabetes. Thus, increased R&D in insulin delivery devices to make them easily accessible to diabetic patients is to drive the growth of the insulin delivery devices industry. The major companies of the insulin delivery devices market are making hefty investments in their R&D department for making new drug approval by the US Food and Drug Administration (FDA).
To Request a Sample of our Report on Insulin Delivery Devices Market: https://www.omrglobal.com/request-sample/insulin-delivery-devices-market-size
Recent Developments
·
In
February 2019, the US FDA had announced the approval of Tandem Diabetes Care’s
t: slim X2 pumps. The t: slim X2 insulin pumps of Tandem Diabetes Care poses
several advanced features like a large color touch screen, Bluetooth,
rechargeable battery, wireless technology, USB connectivity, and watertight
construction. These pumps can make a reliable and secure communication through
digitally connected devices such as insulin dosing software, to receive,
execute, and confirm command from these devices.
·
In
April 2017, Sanofi and Regeneron Pharmaceuticals, Inc. had received approval of
their new supplemental Biologics License Application for a once-monthly 300 mg
dose of Praluent Injection for the treatment of adults with high low-density
lipoprotein cholesterol. The usage of this supplement will improve glycemic
control in adult patients with diabetes. This pen is capable of holding double
the quantity of insulin which is previously available. The injectible pen
SoloStar and the Max SoloStar are capable of delivering up to 160 units of
insulin per injection.
·
In
September 2016, the US FDA announced the approval of Medtronic’s MiniMed 670G
system. This device can automatically monitor the blood glucose level of type1
diabetics and delivers appropriate insulin doses to the patient.
·
The
rapid increase in technological innovation and product development.
·
North
America held a major market share.
·
Asia-Pacific
to show a significant growth rate.
·
Conferences,
meetings, and congresses are to create awareness among people.
·
Intensive
incidence of diabetes across the globe geared the interest of pharmaceutical
companies toward diabetes-related R&D.
·
Partnerships
and collaborations – key drivers of competition in this market.
A
full Report of Insulin Delivery Devices
Market is Available at: https://www.omrglobal.com/industry-reports/insulin-delivery-devices-market-size
Insulin
Delivery Devices Market Segmentation
·
Insulin
Syringes
·
Insulin
Pens
·
Insulin
Jet Injectors
·
Insulin
Pumps
By End-User
Industry
·
Hospitals
& Clinics
·
Homecare
Insulin
Delivery Devices Market – Segment by Region
North America
·
United States
·
Canada
Europe
·
UK
·
Germany
·
Spain
·
France
·
Italy
·
Rest of Europe
Asia-Pacific
·
India
·
China
·
Japan
·
South Korea
·
Rest of APAC
Rest of The World
·
Latin
America
·
Middle
East & Africa
Company
Profiles
·
Animas
LLC
·
Abbott
Laboratories, Inc.
·
B.
Braun Melsungen AG
·
Becton,
Dickinson and Co.
·
Bigfoot
Biomedical Inc.
·
Biocon
Ltd.
·
Eli
Lilly and Co.
·
F.
Hoffmann-La Roche AG
·
Gerresheimer
AG
·
Insulet
Corp.
·
Julphar
·
MannKind
Corp.
·
Medtronic
PLC
·
Novo
Nordisk A/S
·
Sanofi
SA
·
SciGen
Pte Ltd.
·
Tandem
Diabetes Care, Inc.
·
Valeritas
Holdings, Inc.
·
Wockhardt
Ltd.
·
Ypsomed
AG
Reasons to Buy from us –
1. We cover more than
15 major industries, further segmented into more than 90 sectors.
2. More than 120
countries are for analysis.
3. Over 100+ paid
data sources mined for investigation.
4. Our expert
research analysts answer all your questions before and after purchasing your
report.
For More Customized Data, Request for
Report Customization @ https://www.omrglobal.com/report-customization/insulin-delivery-devices-market-size
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company
known for its crisp and concise reports. The company is equipped with an
experienced team of analysts and consultants. OMR offers quality syndicated
research reports, customized research reports, consulting and other
research-based services.
For
More Information, Visit Orion Market Research
Media
Contact:
Company
Name: Orion Market Research
Contact
Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact
no: +91 7803040404
Comments
Post a Comment